What is the use of Antistreptolysin O (ASO) titre in clinical practice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Use of Antistreptolysin O (ASO) Titre

The primary clinical use of Antistreptolysin O (ASO) titre is for confirming recent Group A Streptococcal (GAS) infection in patients with suspected nonsuppurative complications such as acute rheumatic fever or acute glomerulonephritis, not for diagnosing acute pharyngitis. 1

Mechanism and Interpretation

ASO titre measures antibodies produced against streptolysin O, an extracellular antigen produced by Group A Streptococcus. Key characteristics include:

  • Timing: ASO titres begin to rise approximately 1 week after infection and peak 3-6 weeks after infection 1
  • Duration: Elevated titres may persist for several months after uncomplicated GAS infections 1
  • Normal values: Vary by age - higher in school-age children than adults 1
  • Upper limit of normal (ULN): Varies geographically, with studies suggesting values around 262.4 IU/ml in some regions 2

Primary Clinical Applications

1. Diagnosis of Post-Streptococcal Complications

  • Acute Rheumatic Fever (ARF)

    • ASO titre provides evidence of preceding GAS infection required for ARF diagnosis according to Jones criteria 3
    • Most valuable when paired with clinical manifestations (carditis, polyarthritis, chorea, etc.) 3
    • Particularly important in cases with subtle or subclinical presentations
  • Post-Streptococcal Glomerulonephritis

    • Helps establish recent GAS infection as the trigger for nephritis 1

2. Sequential Testing Approach

For optimal diagnostic value:

  • If the initial ASO test is negative but clinical suspicion remains high, an anti-DNase B test should be performed 1, 4
  • Anti-DNase B titres begin to rise 1-2 weeks and peak 6-8 weeks after infection 1
  • Combined testing increases diagnostic sensitivity for confirming recent GAS infection 4

Important Limitations and Pitfalls

  1. Not for acute pharyngitis diagnosis

    • ASO titres reflect past, not present immunologic events 1
    • Cannot distinguish between true infection and carrier state 1
    • Throat culture or rapid antigen detection test is preferred for acute pharyngitis 1
  2. Single measurement limitations

    • A single elevated ASO titre has limited diagnostic value (sensitivity ~66%, specificity ~82%) 5
    • Ideally, paired samples showing a rising titre provide more conclusive evidence 4
  3. Interpretation challenges

    • Age-specific normal ranges must be considered - children have higher normal values than adults 1
    • Geographic variations in ULN exist, potentially leading to misclassification of ARF cases 6
    • Elevated ASO can occur in conditions unrelated to post-streptococcal diseases 7

Best Practices for ASO Testing

  1. When to order:

    • For suspected nonsuppurative complications of GAS (ARF, glomerulonephritis)
    • Not for routine evaluation of acute pharyngitis or sore throat
  2. Optimal testing approach:

    • Order both ASO and anti-DNase B tests when possible 1, 4
    • Consider sequential samples 2-4 weeks apart if timing of infection is unclear
    • Interpret results in context of clinical presentation and local ULN values
  3. Result interpretation:

    • Rising titres are more diagnostically valuable than a single elevated result
    • Consider age-appropriate normal ranges when interpreting results
    • Use in conjunction with clinical criteria for ARF or other post-streptococcal conditions

By understanding these principles, clinicians can appropriately utilize ASO testing to confirm recent GAS infection in patients with suspected post-streptococcal complications while avoiding misdiagnosis from overreliance on single measurements.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Rheumatic Fever

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

How to use antistreptolysin O titre.

Archives of disease in childhood. Education and practice edition, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.